NCT01512849View on ClinicalTrials.gov

A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

TA-7284 Low

Low

DRUG

TA-7284 High

High

Trial Locations (1)

Unknown

Reserch site, Kanto

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY